Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Chelation Products: Unapproved Over-the-Counter Drugs - Consumer Warning

October 14, 2010 10:30 am | by U.S. Food & Drug Administration | News | Comments

Consumers advised to avoid OTC chelation products because of the potential for serious harm associated with their use, including dehydration, kidney failure, and death.

TOPICS:

For non-stick MEMS, turn to quantum physics

October 14, 2010 9:33 am | by I-Micronews | News | Comments

MIT researchers have developed a way to calculate Casimir forces, which could effect the way sub-micron MEMS are designed.

Umicore completes construction of new US based germanium substrates production facility

October 14, 2010 9:33 am | by I-Micronews | News | Comments

Materials technology group Umicore has completed the construction of its new germanium substrates production facility in Quapaw, Oklahoma, USA, adjacent to the existing site.

Advertisement

Tyndall nano-material reduces energy consumption in semiconductor chips

October 14, 2010 9:33 am | by I-Micronews | News | Comments

Tyndall National Institute, UCC announced at the 2010 International Power Supply on Chip Workshop in Cork, the development of a new nano-material that will dramatically reduce the operating temperature of silicon chip components and circuits, thereby enhancing the reliability and lifetime...

Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors

October 14, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Oct. 14 /- OrthoAccel Technologies, Inc., developers of the AcceleDent System , an acceleration device to enhance orthodontics, announced this week that it has engaged Todd Cooper as a Director on its Corporate Board.  Mr. Cooper's directorship will involve oversight and...

TOPICS:

Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies

October 14, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

HOBOKEN, N.J., Oct. 14 /- Octapharma USA is accepting applications for the Octapharma 25th Anniversary Grants Program , which supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immune therapy, intensive care and emergency medicine. The...

TOPICS:

Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C

October 14, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK , N.C., Oct. 14 /- Talecris Biotherapeutics (Nasdaq: TLCR ) announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the...

TOPICS:

BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure

October 14, 2010 9:31 am | by Bio-Medicine.Org | News | Comments

ARLINGTON, Va., Oct. 14 /-  BioInformatics, LLC announces the pending release of three Q4 market reports: RNAi:  Product Usage & Brand Assessment (#10-006) Exploring Structural Biology:  Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)...

TOPICS:
Advertisement

IPC buys 2 physician groups for undisclosed amount

October 14, 2010 8:45 am | by The Associated Press | News | Comments

Physician group practice company IPC The Hospitalist Company Inc. said Thursday it bought two physician groups for an undisclosed amount.The company bought Post-Acute Medical Associates PC, based in Morristown, N.J., and Muhammad Syed MD PC in Las Vegas. The two groups have 20,000 patient...

New report reveals two-thirds of spinal fractures remain undiagnosed and untreated

October 14, 2010 8:34 am | by EurekAlert | News | Comments

(International Osteoporosis Foundation) A new report issued by the International Osteoporosis Foundation for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.

TOPICS:

Genzyme makes employee plans in case of possible takeover

October 14, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

An internal Genzyme Corp. memo, obtained by Mass High Tech, outlines a new employee retention program designed to keep workers from fleeing the company in the midst of layoffs and a potential hostile takeover by French drug maker Sanofi-aventis.

CR Magazine Sheds Light on the Burden of Cancer on the Streets

October 14, 2010 7:31 am | by AACR | News | Comments

PHILADELPHIA — An article published in the Fall 2010 issue of CR, the AACR’s magazine for cancer survivors and their families and caregivers, details the immense challenges faced by those who suffer with cancer and lack the necessary resources for proper treatment and care — the homeless.

TOPICS:

Scientists assess new vaccines to improve health of African children

October 14, 2010 7:31 am | by EurekAlert | News | Comments

(University of Liverpool) Scientists at the University of Liverpool, in partnership with the Malawi Ministry of Health, are investigating the effectiveness of new vaccines developed to protect children from pneumonia and diarrhoea.

TOPICS:

NinePoint Medical snags $33M Series A funding

October 14, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

NinePoint Medical Inc., an in vivo pathology device maker newly headquartered in Cambridge, has closed a $33 million Series A funding round led by Third Rock Ventures and Prospect Venture Partners.

Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research

October 14, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Oct. 14 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced that it is partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). Catherine Chu-Shore, MD, of Massachusetts General Hospital was...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading